AIM
MEDP icon

Artemis Investment Management’s Medpace MEDP Stock Holding History

Artemis Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
37,673
+13,663
+57% +$6.31M 0.18% 129
2026
Q1 		$11.5M Buy
+24,010
New +$12.3M 0.12% 135
2024
Q3 		– Sell
-53,897
Closed -$22.2M – 217
2024
Q2 		$22.2M Buy
+53,897
New +$21.3M 0.3% 93
2023
Q1 		– Sell
-20,838
Closed -$4.45M – 235
2022
Q4 		$4.45M Buy
+20,838
New +$4.16M 0.05% 176

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Artemis Investment Management's MEDP Position: Q2 2026 in Review

Artemis Investment Management increased its Medpace (MEDP) stake by 57% in Q2 2026, buying an estimated $6.31M and bringing the position to 37,673 shares worth $20M. The position accounts for 0.18% of the portfolio, ranked #129.

Artemis Investment Management first reported a position in MEDP in Q4 2022 and has held it in 4 quarters since. The position peaked at $22.2M in Q2 2024. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Artemis Investment Management held 37,673 shares of Medpace worth $20M as of Q2 2026.
  • Artemis Investment Management bought 13,663 Medpace shares in Q2 2026, an estimated $6.31M.
  • Medpace made up 0.18% of Artemis Investment Management's portfolio in Q2 2026, its #129 holding.
  • Artemis Investment Management first reported a position in Medpace in Q4 2022 and has held it in 4 quarters since.
  • Artemis Investment Management's Medpace position peaked at $22.2M in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.